ANEB
Price:
$1.7999
Market Cap:
$46.68M
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.[Read more]
Industry
Biotechnology
IPO Date
2021-05-07
Stock Exchange
NASDAQ
Ticker
ANEB
According to Anebulo Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.86. This represents a change of -37.29% compared to the average of -7.75 of the last 4 quarters.
The mean historical PE Ratio of Anebulo Pharmaceuticals, Inc. over the last ten years is -248.08. The current -4.86 PE Ratio has changed 95.91% with respect to the historical average. Over the past ten years (40 quarters), ANEB's PE Ratio was at its highest in in the June 2021 quarter at -1.07. The PE Ratio was at its lowest in in the September 2020 quarter at -161.08.
Average
-248.08
Median
-11.54
Minimum
-964.21
Maximum
-5.02
Discovering the peaks and valleys of Anebulo Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 238.70%
Maximum Annual PE Ratio = -5.02
Minimum Annual Increase = -99.45%
Minimum Annual PE Ratio = -964.21
Year | PE Ratio | Change |
---|---|---|
2023 | -5.02 | -71.81% |
2022 | -17.82 | 238.70% |
2021 | -5.26 | -99.45% |
The current PE Ratio of Anebulo Pharmaceuticals, Inc. (ANEB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-9.37
5-year avg
-248.08
10-year avg
-248.08
Anebulo Pharmaceuticals, Inc.’s PE Ratio is less than Adagene Inc. (-2.86), less than Acrivon Therapeutics, Inc. Common Stock (-4.23), greater than AnaptysBio, Inc. (-5.77), less than Mineralys Therapeutics, Inc. (-4.63), less than Aerovate Therapeutics, Inc. (-0.62), less than Opthea Limited (-1.11), less than AN2 Therapeutics, Inc. (-0.47), less than PMV Pharmaceuticals, Inc. (0), less than Molecular Partners AG (-1.58), less than null (-2.67),
Company | PE Ratio | Market cap |
---|---|---|
-2.86 | $115.55M | |
-4.23 | $250.26M | |
-5.77 | $1.08B | |
-4.63 | $558.43M | |
-0.62 | $54.85M | |
-1.11 | $444.73M | |
-0.47 | $30.44M | |
0 | $77.28M | |
-1.58 | $182.90M | |
-2.67 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anebulo Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Anebulo Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Anebulo Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Anebulo Pharmaceuticals, Inc. (ANEB)?
What is the highest PE Ratio for Anebulo Pharmaceuticals, Inc. (ANEB)?
What is the 3-year average PE Ratio for Anebulo Pharmaceuticals, Inc. (ANEB)?
What is the 5-year average PE Ratio for Anebulo Pharmaceuticals, Inc. (ANEB)?
How does the current PE Ratio for Anebulo Pharmaceuticals, Inc. (ANEB) compare to its historical average?